AU
UK
CA
US
IND
NZ
Last update at 2026-06-02T13:30:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -52.82930M | -76.00000M | -35.00000M | -181.00000M | 1.00M |
| Minority interest | 0.00000M | 0.00000M | 3.00M | 2.00M | -4.00000M |
| Net income | -68.19782M | -92.00000M | -102.00000M | -221.00000M | -17.00000M |
| Selling general administrative | 265.00M | 133.00M | 140.00M | 182.00M | 155.00M |
| Selling and marketing expenses | - | 162.00M | 170.00M | 249.00M | 231.00M |
| Gross profit | 315.05M | 354.00M | 358.00M | 528.00M | 497.00M |
| Reconciled depreciation | 36.00M | 42.00M | 49.00M | 63.00M | 62.00M |
| Ebit | 46.11M | -60.00000M | 3.00M | -82.00000M | 29.00M |
| Ebitda | 80.68M | -18.00000M | 48.00M | -19.00000M | 91.00M |
| Depreciation and amortization | 34.58M | 42.00M | 45.00M | 63.00M | 62.00M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 46.11M | -48.00000M | -8.00000M | -160.00000M | 9.00M |
| Other operating expenses | 997.03M | 1186.00M | 1158.00M | 1867.00M | 1740.00M |
| Interest expense | 34.58M | 35.00M | 38.00M | 20.00M | 14.00M |
| Tax provision | 7.00M | 15.00M | 48.00M | 42.00M | 15.00M |
| Interest income | 7.00M | 11.00M | 19.00M | 11.00M | 8.00M |
| Net interest income | -21.00000M | -26.00000M | -17.00000M | -12.00000M | -6.00000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 7.68M | 15.00M | 16.00M | 42.00M | 15.00M |
| Total revenue | 1043.14M | 1138.00M | 1150.00M | 1857.00M | 1760.00M |
| Total operating expenses | 268.95M | 402.00M | 366.00M | 538.00M | 477.00M |
| Cost of revenue | 728.08M | 784.00M | 792.00M | 1329.00M | 1263.00M |
| Total other income expense net | -98.93487M | -28.00000M | -27.00000M | -21.00000M | -8.00000M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -63.00000M | -91.00000M | -212.00000M | -223.00000M | -14.00000M |
| Net income applicable to common shares | - | - | - | -221.00000M | -17.00000M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 1275.46M | 1377.00M | 1368.00M | 1756.00M | 2095.00M |
| Intangible assets | 34.99M | 28.00M | 24.00M | 29.00M | 12.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | 23.99M | 118.00M | 130.00M | 14.00M | 15.00M |
| Total liab | 1020.57M | 1052.00M | 972.00M | 1195.00M | 1409.00M |
| Total stockholder equity | 253.89M | 323.00M | 395.00M | 520.00M | 632.00M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 173.93M | 209.00M | 219.00M | 3.00M | -1.00000M |
| Common stock | 25.99M | 187.00M | 187.00M | 187.00M | 187.00M |
| Capital stock | 26.00M | 187.00M | 187.00M | 187.00M | 187.00M |
| Retained earnings | 990.58M | 852.00M | 945.00M | 1042.00M | 1284.00M |
| Other liab | - | - | - | 569.00M | 766.00M |
| Good will | 202.91M | 217.00M | 215.00M | 219.00M | 280.00M |
| Other assets | - | 1.00M | -30.00000M | 1.00M | 257.00M |
| Cash | 90.96M | 68.00M | 77.00M | 138.00M | 398.00M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 402.83M | 396.00M | 388.00M | 585.00M | 597.00M |
| Current deferred revenue | 102.96M | - | 97.00M | 309.00M | 319.00M |
| Net debt | 77.97M | 88.00M | 6.00M | -73.00000M | -325.00000M |
| Short term debt | 16.99M | 15.00M | 14.00M | 24.00M | 27.00M |
| Short long term debt | 0.00000M | 0.00000M | 0.00000M | 4.00M | 3.00M |
| Short long term debt total | 168.93M | 156.00M | 83.00M | 65.00M | 73.00M |
| Other stockholder equity | 161.93M | -716.00000M | -737.00000M | -709.00000M | -839.00000M |
| Property plant equipment | - | - | - | 152.00M | 197.00M |
| Total current assets | 718.69M | 793.00M | 792.00M | 1153.00M | 1339.00M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | - | 273.00M | 339.00M |
| Short term investments | - | - | 71.00M | 1.00M | 2.00M |
| Net receivables | 349.85M | 314.00M | 296.00M | 513.00M | 506.00M |
| Long term debt | 111.00M | 105.00M | 39.00M | -1.00000M | -1.00000M |
| Inventory | 253.89M | 293.00M | 289.00M | 487.00M | 418.00M |
| Accounts payable | 108.95M | 127.00M | 132.00M | 249.00M | 252.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -924.60631M | - | -948.00000M | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 73.97M | 116.00M | 148.00M | 108.00M | 134.00M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 556.76M | 583.00M | 576.00M | 602.00M | 756.00M |
| Capital lease obligations | 58.00M | 51.00M | 43.00M | 62.00M | 71.00M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -29.00000M | -19.00000M | -76.00000M | -2.00000M |
| Change to liabilities | - | - | - | -15.00000M | 41.00M |
| Total cashflows from investing activities | -24.97385M | -29.00000M | -16.00000M | -76.00000M | -2.00000M |
| Net borrowings | 5.00M | 65.00M | 40.00M | -31.00000M | -30.00000M |
| Total cash from financing activities | -12.48692M | 22.00M | -10.00000M | -77.00000M | -67.00000M |
| Change to operating activities | - | - | - | -174.00000M | -296.00000M |
| Net income | -60.51356M | -92.00000M | -101.00000M | -223.00000M | -14.00000M |
| Change in cash | 31.03M | -9.00000M | -61.00000M | -260.00000M | -187.00000M |
| Begin period cash flow | 59.93M | 77.00M | 138.00M | 398.00M | 585.00M |
| End period cash flow | 90.96M | 68.00M | 77.00M | 138.00M | 398.00M |
| Total cash from operating activities | 63.40M | -4.00000M | -30.00000M | -100.00000M | -116.00000M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 34.58M | 42.00M | 45.00M | 63.00M | 62.00M |
| Other cashflows from investing activities | - | 15.00M | 20.00M | 4.00M | 4.00M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | 22.09M | -13.00000M | 23.00M | -65.00000M | -48.00000M |
| Change to account receivables | - | 5.00M | -12.00000M | 11.00M | -2.00000M |
| Sale purchase of stock | 0.00000M | 0.00000M | 0.00000M | -21.00000M | -29.00000M |
| Other cashflows from financing activities | -17.28959M | -43.00000M | -50.00000M | -52.00000M | -35.00000M |
| Change to netincome | - | - | - | 301.00M | 144.00M |
| Capital expenditures | 32.66M | 45.00M | 34.00M | 33.00M | 26.00M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -69.15835M | -10.00000M | -157.00000M | -67.00000M | 7.00M |
| Stock based compensation | - | - | - | - | - |
| Other non cash items | 158.49M | 56.00M | 183.00M | 127.00M | -171.00000M |
| Free cash flow | 30.74M | -49.00000M | -64.00000M | -133.00000M | -142.00000M |
Sector: Industrials Industry: Specialty Industrial Machinery
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AFGVY Agfa Gevaert NV ADR |
- -% | 2.29 | - | 11.89 | 0.16 | 0.52 | 0.17 | 10.57 |
| GEV GE Vernova LLC |
-8.555 0.89% | 950.80 | 56.16 | 67.57 | 7.02 | 23.82 | 6.79 | 115.11 |
| ETN Eaton Corporation PLC |
-4.7409 1.13% | 416.47 | 39.21 | 30.77 | 5.80 | 8.18 | 6.15 | 27.30 |
| SIEGY Siemens AG ADR |
-1.2 0.75% | 158.00 | 17.07 | 15.75 | 1.88 | 2.76 | 2.37 | 11.38 |
| SMAWF Siemens AG Class N |
-5.0 1.58% | 312.00 | 16.98 | 15.53 | 1.83 | 2.72 | 2.35 | 11.32 |
Agfa-Gevaert NV develops, manufactures, and markets various analog and digital systems worldwide. It operates through four segments: HealthCare IT, Digital Print and Chemicals, Radiology Solutions, and Contractor Operations and Services (CONOPS). The Healthcare IT segment provides healthcare's enterprise imaging platform. The Digital Print & Chemicals segment offers printers, inks, and software for sign and display and packaging printing companies; inkjet inks and fluids for various industrial inkjet applications, such as signs, displays, billboards, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; electrolysis membranes to the hydrogen production industry; and printable synthetic papers and films for graphics, non-destructive testing, aerial photography, and printed circuit board production. The Radiology Solutions segment provides analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing software. This segment also offers SmartXR that provides radiographers with predictive workflow assistance which includes digital radiography tools for dose, alignment, patient positioning, image rotation, and others. The CONOPS segment engages in supply of film and chemicals, as well support services. It sells its products through its own sales organization, as well as through a network of agents and representatives. Agfa-Gevaert NV was founded in 1867 and is headquartered in Mortsel, Belgium.
Septestraat 27, Mortsel, Belgium, 2640
| Name | Title | Year Born |
|---|---|---|
| Mr. Pascal Juery | Pres, CEO, Pres of Radiology Solutions & Director | 1965 |
| Mr. Dirk De Man | Chief Financial Officer | NA |
| Mr. Wilfried Van Lishout | Compliance Officer & Company Sec. | 1964 |
| Ms. Viviane Dictus | Director of Corp. Communications | NA |
| Mr. Gunther Koch | Chief HR Officer | 1971 |
| Mr. - Boyer | Exec. VP | NA |
| Mr. Luc Delagaye | Pres of Offset Solutions | 1960 |
| Mr. Vincent Wille | Pres of Digital Print & Chemicals | 1976 |
| Jose Herraez | DR Global Head of Commerce | NA |
| Mr. Scott Evers | Sr. VP & North American Bus. Leader | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...